Details of the Drug

General Information of Drug (ID: DMMT5Q4)

Drug Name

Amantidine

Synonyms

adamantan-1-amine; 1-Adamantylamine; 1-Aminoadamantane; Adamantanamine; Adamantylamine; Aminoadamantane; Symmetrel; 1-Adamantanamine; 768-94-5; Amantidine; Pk-merz; Adamantamine; Symadine; 1-Adamantamine; Amantadinum; Amantadina; Amantadine [INN:BAN]; Amantadinum [INN-Latin]; Amantadina [INN-Spanish]; adamantan-1-ylamine; Gocovri; TCMDC-125869; 1-adamantaneamine; UNII-BF4C9Z1J53; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; NSC 341865; Tricyclo(3.3.1.13,7)decan-1-amine; HSDB 3202; tricyclo[3.3.1.1~3,7~]decan-1-amine; Tricyclo[3.

Indication

Disease Entry	ICD 11	Status	REF
Influenza virus infection	1E30-1E32	Approved	[1]
Severe acute respiratory syndrome (SARS)	1D65	Investigative	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C10H17N
Canonical SMILES: C1C2CC3CC1CC(C2)(C3)N
InChI: 1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2
InChIKey: DKNWSYNQZKUICI-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 2130
ChEBI ID: CHEBI:2618
CAS Number: 768-94-5
TTD ID: D09MCG

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 209171.
2	Coronavirus envelope protein: current knowledge. Virol J. 2019 May 27;16(1):69.